Literature DB >> 30140795

Boron reagents for divergent radiochemistry.

Thomas C Wilson1, Thomas Cailly, Véronique Gouverneur.   

Abstract

Radiolabelled (bio)molecules have advanced many areas of science from fundamental biology to human health including applications in molecular imaging and more generally nuclear medicine. Today, the field of radiochemistry is rapidly expanding, a trend resulting from the increasing demand for labelled molecules necessary for diagnosis and to accelerate pharmaceutical drug development. More often, the synthesis of labelled (bio)molecules employs a pre-functionalised precursor to allow for the chemoselective installation of a particular radioisotope-containing substituent. Among the array of precursors available, boron reagents occupy a prominent place because they are easy to handle, numerous possibilities exist for their preparation, and their reactivity has been well studied especially in cross-coupling chemistry. In this review, we discuss the value of boron-based precursors for the radiolabelling of (bio)molecules with the radionuclides carbon-11, fluorine-18, iodine-123, iodine-125 and iodine-131, and we illustrate how these radiosynthetic advances have opened the radiochemical space available for areas such as PET and SPECT imaging.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30140795     DOI: 10.1039/c8cs00499d

Source DB:  PubMed          Journal:  Chem Soc Rev        ISSN: 0306-0012            Impact factor:   54.564


  9 in total

1.  NHC-Copper Mediated Ligand-Directed Radiofluorination of Aryl Halides.

Authors:  Liam S Sharninghausen; Allen F Brooks; Wade P Winton; Katarina J Makaravage; Peter J H Scott; Melanie S Sanford
Journal:  J Am Chem Soc       Date:  2020-04-10       Impact factor: 15.419

Review 2.  Radiolabeling with [11C]HCN for Positron emission tomography.

Authors:  Yu-Peng Zhou; Katarina J Makaravage; Pedro Brugarolas
Journal:  Nucl Med Biol       Date:  2021-09-25       Impact factor: 2.408

3.  Manual and automated Cu-mediated radiosynthesis of the PARP inhibitor [18F]olaparib.

Authors:  Florian Guibbal; Patrick G Isenegger; Thomas C Wilson; Anna Pacelli; Damien Mahaut; Jeroen B I Sap; Nicholas J Taylor; Stefan Verhoog; Sean Preshlock; Rebekka Hueting; Bart Cornelissen; Véronique Gouverneur
Journal:  Nat Protoc       Date:  2020-02-28       Impact factor: 13.491

4.  Modular Generation of (Iodinated) Polyarenes Using Triethylgermane as Orthogonal Masking Group.

Authors:  Tatjana Kreisel; Marvin Mendel; Adele E Queen; Kristina Deckers; Daniel Hupperich; Julian Riegger; Christoph Fricke; Franziska Schoenebeck
Journal:  Angew Chem Int Ed Engl       Date:  2022-03-21       Impact factor: 16.823

5.  Investigation on the reactivity of nucleophilic radiohalogens with arylboronic acids in water: access to an efficient single-step method for the radioiodination and astatination of antibodies.

Authors:  Marion Berdal; Sébastien Gouard; Romain Eychenne; Séverine Marionneau-Lambot; Mikaël Croyal; Alain Faivre-Chauvet; Michel Chérel; Joëlle Gaschet; Jean-François Gestin; François Guérard
Journal:  Chem Sci       Date:  2020-11-23       Impact factor: 9.825

6.  Improved synthesis of SV2A targeting radiotracer [11C]UCB-J.

Authors:  Johanna Rokka; Eva Schlein; Jonas Eriksson
Journal:  EJNMMI Radiopharm Chem       Date:  2019-11-29

7.  Silicon compounds in carbon-11 radiochemistry: present use and future perspectives.

Authors:  Federico Luzi; Antony D Gee; Salvatore Bongarzone
Journal:  Org Biomol Chem       Date:  2021-07-28       Impact factor: 3.876

8.  A concise method for fully automated radiosyntheses of [18F]JNJ-46356479 and [18F]FITM via Cu-mediated 18F-fluorination of organoboranes.

Authors:  Gengyang Yuan; Timothy M Shoup; Sung-Hyun Moon; Anna-Liisa Brownell
Journal:  RSC Adv       Date:  2020-07-02       Impact factor: 4.036

9.  Orthogonal Stability and Reactivity of Aryl Germanes Enables Rapid and Selective (Multi)Halogenations.

Authors:  Christoph Fricke; Kristina Deckers; Franziska Schoenebeck
Journal:  Angew Chem Int Ed Engl       Date:  2020-08-20       Impact factor: 16.823

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.